三糖糖-腰部高度比率指数和过度活跃的膀之间的关联:根据NHANES 2005-2018
Haiyan Mao1, Tong Lin1, Shanshan Huang1
1Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
Frontiers in endocrinology
|April 30, 2025
概括
三糖糖-腰高度比率 (TyG-WHtR) 指数与过度活跃膀 (OAB) 的更高风险有关. 这种代谢标志物显示出预测成年人OAB发展的潜力.
科学领域:
- 代谢健康和泌尿病学
- 心血管和代谢疾病风险因素 心血管和代谢疾病风险因素
- 公共卫生和流行病学
背景情况:
- 三糖糖-腰高度比率 (TyG-WHtR) 指数被认为可以预测心血管和代谢疾病.
- 代谢性疾病是过度活性膀 (OAB) 的确立危险因素.
- 泰格-WHtR指数与OAB风险之间的关联以前没有被调查过.
研究的目的:
- 调查TyG-WHtR指数与发展过度活跃膀 (OAB) 的风险之间的关系.
- 评估TyG-WHtR指数对OAB的预测值.
- 探索TyG-WHtR对OAB风险的潜在非线性关系和值影响.
主要方法:
- 利用了来自全国健康和营养检查调查 (NHANES) 的数据,对14,652名成年人进行了调查.
- 进行了加权多变量逻辑回归,子组分析和相互作用测试.
- 采用平滑曲线拟合,值效应分析和接收器操作特征 (ROC) 曲线分析.
主要成果:
- 在TyG-WHtR指数和OAB发生 (OR=1.646,P<0.001) 之间发现了显著的正相关性,在调整后仍然存在 (OR=1.310,P<0.001).
- 这种关联受性别和年龄的影响,在TyG-WHtR观察到的值效应为3.579.
- TyG-WHtR指数显示了OAB的良好预测能力,其AUC为0.647.
结论:
- TyG-WHtR指数与OAB发生有显著的关联,可以作为一种新的风险预测指标.
- 研究结果表明,OAB的早期检测策略具有潜在的实用性.
- 建议进行进一步的研究,以确认因果关系,并在不同人群中验证这些发现.
相关概念视频
Obesity
300
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
300
Diabetes: Symptoms, Diagnosis, and Complications
471
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
471
Oral Hypoglycemic Agents: Biguanides and Glitazones
133
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
133


